Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.


Journal

Nature reviews. Cancer
ISSN: 1474-1768
Titre abrégé: Nat Rev Cancer
Pays: England
ID NLM: 101124168

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 16 3 2019
medline: 21 5 2019
entrez: 16 3 2019
Statut: ppublish

Résumé

Recent reports have demonstrated that oncogene amplification on extrachromosomal DNA (ecDNA) is a frequent event in cancer, providing new momentum to explore a phenomenon first discovered several decades ago. The direct consequence of ecDNA gains in these cases is an increase in DNA copy number of the oncogenes residing on the extrachromosomal element. A secondary effect, perhaps even more important, is that the unequal segregation of ecDNA from a parental tumour cell to offspring cells rapidly increases tumour heterogeneity, thus providing the tumour with an additional array of responses to microenvironment-induced and therapy-induced stress factors and perhaps providing an evolutionary advantage. This Perspectives article discusses the current knowledge and potential implications of oncogene amplification on ecDNA in cancer.

Identifiants

pubmed: 30872802
doi: 10.1038/s41568-019-0128-6
pii: 10.1038/s41568-019-0128-6
pmc: PMC7168519
mid: NIHMS1067253
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

283-288

Subventions

Organisme : NCI NIH HHS
ID : R01 CA190121
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG004962
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA034196
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS073831
Pays : United States
Organisme : NIH HHS
ID : R01 CA190121
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM114362
Pays : United States
Organisme : NIH HHS
ID : P30CA034196
Pays : United States

Références

G3 (Bethesda). 2017 Oct 5;7(10):3295-3303
pubmed: 28801508
J Appl Genet. 2011 Feb;52(1):53-9
pubmed: 21107781
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Cancer Genet Cytogenet. 1987 Nov;29(1):165-70
pubmed: 3478127
Cell. 1981 Nov;26(3 Pt 1):355-62
pubmed: 7326744
Cancer Cell. 2011 Dec 13;20(6):810-7
pubmed: 22137795
Cell. 2017 Nov 30;171(6):1259-1271.e11
pubmed: 29107330
Cell. 1983 Dec;35(2 Pt 1):359-67
pubmed: 6197179
Genome Res. 2010 Sep;20(9):1198-206
pubmed: 20631050
Science. 2012 Apr 6;336(6077):82-6
pubmed: 22403181
Nature. 2016 Jan 7;529(7584):110-4
pubmed: 26700815
Mol Cell Biol. 1989 Jan;9(1):109-15
pubmed: 2648129
Lancet. 1965 Jul 10;1(7402):55-8
pubmed: 14304929
Nat Commun. 2018 Mar 14;9(1):1069
pubmed: 29540679
Genes Dev. 2013 Jul 1;27(13):1462-72
pubmed: 23796897
Microbiol Mol Biol Rev. 2003 Jun;67(2):277-301, table of contents
pubmed: 12794193
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
Br J Pharmacol. 2008 Mar;153 Suppl 1:S347-57
pubmed: 18193080
Proc Natl Acad Sci U S A. 1979 Apr;76(4):1648-52
pubmed: 377280
Acta Neuropathol. 2019 Jan;137(1):123-137
pubmed: 30267146
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6
pubmed: 22323597
Science. 2016 Mar 25;351(6280):1454-1458
pubmed: 26940867
Science. 2014 Jan 3;343(6166):72-6
pubmed: 24310612
Cancer Res. 1991 Dec 1;51(23 Pt 1):6273-9
pubmed: 1682044
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):E3114-22
pubmed: 26038577
PLoS One. 2013;8(2):e56185
pubmed: 23441165
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11368-73
pubmed: 15269346
Nucleic Acids Res. 2014 Aug;42(14):9131-45
pubmed: 25034695
Science. 1991 Nov 22;254(5035):1153-60
pubmed: 1957167
Nature. 2010 Feb 18;463(7283):899-905
pubmed: 20164920
Nat Biotechnol. 2009 Dec;27(12):1181-5
pubmed: 19935656
Cell. 2013 Apr 11;153(2):307-19
pubmed: 23582322
Cytogenet Genome Res. 2004;107(1-2):55-67
pubmed: 15305057
Cell. 2018 Jun 14;173(7):1755-1769.e22
pubmed: 29754820
Trends Cell Biol. 2017 Dec;27(12):917-930
pubmed: 28899600
Trends Genet. 2018 Apr;34(4):270-278
pubmed: 29329720
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
Mol Cell Biol. 1988 Apr;8(4):1525-33
pubmed: 2898098
Nature. 2017 Mar 2;543(7643):122-125
pubmed: 28178237
Nat Rev Cancer. 2008 Jan;8(1):56-61
pubmed: 18059462
Cell. 2013 Mar 28;153(1):17-37
pubmed: 23540688
Proc Natl Acad Sci U S A. 1965 Feb;53:356-62
pubmed: 14294069
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6142-6
pubmed: 118461
Nat Commun. 2019 Jan 23;10(1):392
pubmed: 30674876
J Biol Chem. 1981 Sep 25;256(18):9501-10
pubmed: 7287696
Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8165-9
pubmed: 1518843
Cancer Cell. 2018 Aug 13;34(2):197-210.e5
pubmed: 30017478
Nat Genet. 2018 May;50(5):708-717
pubmed: 29686388
Proc Natl Acad Sci U S A. 1983 Mar;80(6):1707-11
pubmed: 6300869
Oncogene. 1997 Feb 27;14(8):977-85
pubmed: 9050997
Nat Commun. 2014 Dec 04;5:5690
pubmed: 25471132
Cell. 1984 Sep;38(2):431-9
pubmed: 6467372
Genome Res. 2013 May;23(5):762-76
pubmed: 23410887
Nature. 2012 Apr 11;485(7398):376-80
pubmed: 22495300
Genetics. 2018 Mar;208(3):951-961
pubmed: 29279323
Cell. 1984 Jul;37(3):705-13
pubmed: 6378386
Nucleic Acids Res. 2018 Dec 14;46(22):e131
pubmed: 30551175
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20489-93
pubmed: 21059955
Cell. 2013 Mar 14;152(6):1226-36
pubmed: 23498933
Cell. 2015 Aug 13;162(4):911-23
pubmed: 26276637
Nat Rev Cancer. 2007 Apr;7(4):233-45
pubmed: 17361217
J Biol Chem. 1978 Mar 10;253(5):1357-70
pubmed: 627542
Cell. 1989 Jun 16;57(6):901-8
pubmed: 2661014
Hum Mol Genet. 2006 Mar 15;15(6):933-42
pubmed: 16452126
Cancer Cell. 2014 Nov 10;26(5):653-67
pubmed: 25517748
Nat Med. 2017 Aug;23(8):929-937
pubmed: 28714990

Auteurs

Roel G W Verhaak (RGW)

The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. roel.verhaak@jax.org.

Vineet Bafna (V)

Computer Science and Engineering, University of California San Diego, La Jolla, CA, USA. vbafna@eng.ucsd.edu.

Paul S Mischel (PS)

Ludwig Institute for Cancer Research, San Diego, La Jolla, CA, USA. pmischel@ucsd.edu.
UCSD School of Medicine, La Jolla, CA, USA. pmischel@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH